26 C
Vientiane
Thursday, April 24, 2025
spot_img

Cision PR Newswire

Cloud4C Partners with ORIX Rentec to Launch GPU Cloud in Japan, Accelerating Security-first Enterprise AI Transformations

SINGAPORE, April 24, 2025 /PRNewswire/ -- Cloud4C, world's leading multi-cloud MSP and a trusted AI transformation partner, announces its partnership with ORIX Rentec Corporation ("ORIX Rentec"), a group company of ORIX, which is a diversified multinational financial services group, to render GPU Cloud services in Japan. Cloud4C will...

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

SHANGHAI and NORTH CHICAGO, Ill., Jan. 13, 2025 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc....

LG Innotek Reasserts Its Leadership in the Future Mobility Market at CES 2025

Exhibition booth attracts 65,000 cumulative visitors, showcasing innovative mobility components Innovative technologies presented through a 'User-Centric storytelling' approach elicit strong acclaim, inquiries from...

Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine

- Preparing for Phase 2 Global Trials of a Ferritin Platform-Based Virus-Like Particle Universal Coronavirus Vaccine - Based on the Excellent Safety and Immune Response in...

Trillium Flow Technologies Successfully Completes Refinancing

STAMFORD, Conn., Jan. 13, 2025 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve, and a global designer, manufacturer, and aftermarket...

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed...

Neuromodulation Wristband ObeEnd Reduces Heart Rate and Perceived Exercise Exertion

VANCOUVER, BC, Jan. 13, 2025 /PRNewswire/ -- WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd, the...